No. 3 NJoy was unchanged at 2.8 percent, while Fontem Ventures’ blu was unchanged at 1.4 percent.Read More
Tags :Vuse
Vuse’s share rose from 39% in the previous report to 39.7%, while Juul fell from 29.4% to 28.1%.Read More
A jury finds that Vuse Alto infringes three Altria patents.Read More
BAT is accelerating the pace of price hikes for its e-cigarette brands and traditional tobacco products.Read More
Vuse’s share rose from 37.4% in the previous report to 39%, with Juul declining from 30.7% to 29.4%.Read More
Vuse’s market share rose from 35.1 percent to 35.5 percent, while Juul declined from 33.1 to 32.9 percent.Read More
The recent FDA ruling opens the door to market dominance, says financial advice company. Read More
A federal court jury said RJR's Vuse Solo and Alto devices infringe two Philip Morris patents.Read More
The “real world” public-health effects of BAT's Vuse e-cigarette device is the subject of a new study.Read More
The Vuse e-cigarette brand has expanded its U.S. market share to two full percentage points over Juul.Read More
